9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

C218H140N36 — CID 157058356

About 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (PubChem CID 157058356) has the molecular formula C218H140N36 and a molecular weight of 3263.77 g/mol. Its IUPAC name is 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.

Molecular Properties

• Compound Name: 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
• PubChem CID: 157058356
• Molecular Formula: C218H140N36
• Molecular Weight: 3263.77 g/mol
• Exact Mass: 3261.21
• IUPAC Name: 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
• SMILES: Cn1cnc2c(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)ncnc21.Cn1cnc2nc(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)ncc21.c1ccc(-c2cnc3c(n2)nc(-n2c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc42)n3-c2ccccc2)cc1.c1ccc(-c2nc(-c3ccccc3)c3c(n2)nc(-n2c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc42)n3-c2ccccc2)cc1.c1ccc(-n2cnc3c(-n4c5ccccc5c5c6c7ccccc7n(-c7ccccc7)c6ccc54)ncnc32)cc1.c1ccc(-n2cnc3nc(-n4c5ccccc5c5c6c7ccccc7n(-c7ccccc7)c6ccc54)ncc32)cc1
• InChI: InChI=1S/C47H30N6.C41H26N6.2C35H22N6.2C30H20N6/c1-5-17-31(18-6-1)43-44-46(49-45(48-43)32-19-7-2-8-20-32)50-47(52(44)34-23-11-4-12-24-34)53-38-28-16-14-26-36(38)42-40(53)30-29-39-41(42)35-25-13-15-27-37(35)51(39)33-21-9-3-10-22-33;1-4-14-27(15-5-1)32-26-42-40-39(43-32)44-41(46(40)29-18-8-3-9-19-29)47-34-23-13-11-21-31(34)38-36(47)25-24-35-37(38)30-20-10-12-22-33(30)45(35)28-16-6-2-7-17-28;1-3-11-23(12-4-1)39-22-38-33-34(39)36-21-37-35(33)41-28-18-10-8-16-26(28)32-30(41)20-19-29-31(32)25-15-7-9-17-27(25)40(29)24-13-5-2-6-14-24;1-3-11-23(12-4-1)39-22-37-34-31(39)21-36-35(38-34)41-28-18-10-8-16-26(28)33-30(41)20-19-29-32(33)25-15-7-9-17-27(25)40(29)24-13-5-2-6-14-24;1-34-18-33-28-29(34)31-17-32-30(28)36-23-14-8-6-12-21(23)27-25(36)16-15-24-26(27)20-11-5-7-13-22(20)35(24)19-9-3-2-4-10-19;1-34-18-32-29-26(34)17-31-30(33-29)36-23-14-8-6-12-21(23)28-25(36)16-15-24-27(28)20-11-5-7-13-22(20)35(24)19-9-3-2-4-10-19/h1-30H;1-26H;2*1-22H;2*2-18H,1H3
• InChIKey: ABADBHZTQUYTFV-UHFFFAOYSA-N
• XLogP: 50.15
• TPSA: 320.76 Ų
• H-Bond Acceptors: 36
• Rotatable Bonds: 19
• Heavy Atoms: 254
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3263.77
LogP ≤ 5	50.15
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	36

Frequently Asked Questions

What is the IUPAC name of 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The IUPAC name of 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (CID 157058356) is 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.

What is the SMILES notation for 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The canonical SMILES for 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is Cn1cnc2c(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)ncnc21.Cn1cnc2nc(-n3c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc43)ncc21.c1ccc(-c2cnc3c(n2)nc(-n2c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc42)n3-c2ccccc2)cc1.c1ccc(-c2nc(-c3ccccc3)c3c(n2)nc(-n2c4ccccc4c4c5c6ccccc6n(-c6ccccc6)c5ccc42)n3-c2ccccc2)cc1.c1ccc(-n2cnc3c(-n4c5ccccc5c5c6c7ccccc7n(-c7ccccc7)c6ccc54)ncnc32)cc1.c1ccc(-n2cnc3nc(-n4c5ccccc5c5c6c7ccccc7n(-c7ccccc7)c6ccc54)ncc32)cc1.

What is the InChIKey of 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The InChIKey is ABADBHZTQUYTFV-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H30N6.C41H26N6.2C35H22N6.2C30H20N6/c1-5-17-31(18-6-1)43-44-46(49-45(48-43)32-19-7-2-8-20-32)50-47(52(44)34-23-11-4-12-24-34)53-38-28-16-14-26-36(38)42-40(53)30-29-39-41(42)35-25-13-15-27-37(35)51(39)33-21-9-3-10-22-33;1-4-14-27(15-5-1)32-26-42-40-39(43-32)44-41(46(40)29-18-8-3-9-19-29)47-34-23-13-11-21-31(34)38-36(47)25-24-35-37(38)30-20-10-12-22-33(30)45(35)28-16-6-2-7-17-28;1-3-11-23(12-4-1)39-22-38-33-34(39)36-21-37-35(33)41-28-18-10-8-16-26(28)32-30(41)20-19-29-31(32)25-15-7-9-17-27(25)40(29)24-13-5-2-6-14-24;1-3-11-23(12-4-1)39-22-37-34-31(39)21-36-35(38-34)41-28-18-10-8-16-26(28)33-30(41)20-19-29-32(33)25-15-7-9-17-27(25)40(29)24-13-5-2-6-14-24;1-34-18-33-28-29(34)31-17-32-30(28)36-23-14-8-6-12-21(23)27-25(36)16-15-24-26(27)20-11-5-7-13-22(20)35(24)19-9-3-2-4-10-19;1-34-18-32-29-26(34)17-31-30(33-29)36-23-14-8-6-12-21(23)28-25(36)16-15-24-27(28)20-11-5-7-13-22(20)35(24)19-9-3-2-4-10-19/h1-30H;1-26H;2*1-22H;2*2-18H,1H3.

What are the key properties of 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene has a molecular weight of 3263.77 g/mol, XLogP of 50.15, 19 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 9-(1,5-diphenylimidazo[4,5-b]pyrazin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(7-methylpurin-2-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(9-methylpurin-6-yl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(7-phenylpurin-2-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(9-phenylpurin-6-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-phenyl-14-(2,6,7-triphenylpurin-8-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is sourced from PubChem (CID 157058356), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).